FR2235678B1 - - Google Patents

Info

Publication number
FR2235678B1
FR2235678B1 FR7422648A FR7422648A FR2235678B1 FR 2235678 B1 FR2235678 B1 FR 2235678B1 FR 7422648 A FR7422648 A FR 7422648A FR 7422648 A FR7422648 A FR 7422648A FR 2235678 B1 FR2235678 B1 FR 2235678B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7422648A
Other languages
French (fr)
Other versions
FR2235678A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2235678A1 publication Critical patent/FR2235678A1/en
Application granted granted Critical
Publication of FR2235678B1 publication Critical patent/FR2235678B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
FR7422648A 1973-07-02 1974-06-28 Topical antipsoriasis agents - contg. prostaglandin E1 or E2 Granted FR2235678A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37558873A 1973-07-02 1973-07-02

Publications (2)

Publication Number Publication Date
FR2235678A1 FR2235678A1 (en) 1975-01-31
FR2235678B1 true FR2235678B1 (en) 1977-11-04

Family

ID=23481471

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7422648A Granted FR2235678A1 (en) 1973-07-02 1974-06-28 Topical antipsoriasis agents - contg. prostaglandin E1 or E2

Country Status (2)

Country Link
DE (1) DE2431558A1 (en)
FR (1) FR2235678A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2821737A1 (en) * 1977-05-20 1978-11-30 Wellcome Found PHARMACEUTICAL PREPARATION TO PREVENT THROMBOCYTE AGGREGATION
US4337254A (en) 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
GB8501488D0 (en) * 1985-01-21 1985-02-20 Beecham Group Plc Treatment
IT1253431B (en) * 1991-12-02 1995-08-08 Valetudo S R L PHARMACEUTICAL PREPARATIONS FOR TOPICAL USE FOR THE TREATMENT OF PSORIASIS AND ATOPIC DERMATITIS
WO1998000100A1 (en) * 1996-07-03 1998-01-08 The Board Of Regents Of The University Of Oklahoma Enhancement of skin pigmentation by prostaglandins
CA3125226C (en) * 2018-12-29 2023-10-10 Shanghai Archeus Biotech Co., Ltd. Immunosuppressive pharmaceutical composition and use thereof

Also Published As

Publication number Publication date
FR2235678A1 (en) 1975-01-31
DE2431558A1 (en) 1975-01-23

Similar Documents

Publication Publication Date Title
AR201758A1 (en)
AU476761B2 (en)
AU465372B2 (en)
AR201235Q (en)
AR201231Q (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU465453B2 (en)
AU471343B2 (en)
AU450229B2 (en)
AU476714B2 (en)
AR201229Q (en)
AU472848B2 (en)
AU476696B2 (en)
AU466283B2 (en)
AR199451A1 (en)
AU477823B2 (en)
AR201432A1 (en)
AU461342B2 (en)
AU447540B2 (en)
AR195311A1 (en)
AR193950A1 (en)
AR210729A1 (en)
AU477824B2 (en)

Legal Events

Date Code Title Description
ST Notification of lapse